首页 | 本学科首页   官方微博 | 高级检索  
检索        

用逆转录─多聚酶链反应检测卵巢癌及大肠癌患者多药耐药基因的表达
引用本文:徐建业,周琦,沈平,李福沛,李伟道.用逆转录─多聚酶链反应检测卵巢癌及大肠癌患者多药耐药基因的表达[J].重庆医学,1997(1).
作者姓名:徐建业  周琦  沈平  李福沛  李伟道
作者单位:重庆肿瘤研究所!630030
摘    要:应用逆转录─多聚酶键反应(RT-PCR)检测卵巢癌12例,大肠癌15例,肝癌2例肿瘤多药耐药基因(MDR1)表达。以长春新碱(VCR)敏感细胞株KB和耐药株KBr分别作阴性及阳性对照,卵巢癌患者MDR1表达增高者为50%(6/12),大肠癌增高者75%(10/15)卵巢癌MDR1表达低者化疗效果较好;大肠癌患者MDR1表达高者似与术前局部用化疗药有关。

关 键 词:肿瘤多药耐药基因  逆转录多聚酶链反应  卵巢癌  大肠癌

DETERNIRATION OF MIDR_1 GENE EXPRESSION IN PATIENTS WITH OVARIAN CANCER OF COLORECTAL CANCER WITH RT-PCR
Xu Jianye, et al.DETERNIRATION OF MIDR_1 GENE EXPRESSION IN PATIENTS WITH OVARIAN CANCER OF COLORECTAL CANCER WITH RT-PCR[J].Chongqing Medical Journal,1997(1).
Authors:Xu Jianye  
Abstract:Used VCR-sensitive KB cell line and VCR-resistant KBr cell line as negative and positive control respectively,the authors deterned Multiple Drug Resistant qene 1 (MDR1) mRNA in patients with ovarian cancer or colorectal cancer with RT-PCR. High level expression of MDR1 was found in 6/12 of ovarian cancer and 10/15 of colorectal cancer. The deternination of MDR1 may be helpfulin designing chemotherapeutic protocols in the patients with luqh level expression of MDR1
Keywords:MDR_1 RT-PCR Ovarian cancer coloretalcancer  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号